Could silver nano-particles control the 2019-nCoV virus?; An urgent glance to the past

Document Type : Review Article


1 Department of Chemistry, Qaemshahr Branch, Islamic Azad University, Qaemshahr, Iran

2 No.702, Navab st, Azadi st, Tehran, (P.O.BOX: 14195-371) Iran


2019-nCoV, this tiny crowned virus, which was first spread from Wuhan, China, killed thousands of peoples in China, Italy, Iran, and Spain, in a very short period of time. Now, it reaches to most countries all around the world, and thus, it becomes one of the most important threats against all human race. The fact is, the outbreak of this virus showed us, how much our science about the new viruses is weak and insufficient. In the near future, we have to revolutionary increase our knowledge about viruses and controlling those species.
Due to the recent reports about the effect of silver nanoparticles (AgNPs) (in vitro and in vivo) on corona virus family especially influenzas, in this study, we have made attempts to take a glance on the effect of AgNPs on the viruses, and ask ourselves "may nano particles inhibit the 2019-nCoV?"

Graphical Abstract

Could silver nano-particles control the 2019-nCoV virus?; An urgent glance to the past


[1] S.L. Percival, P.G. Bowler, J. Dolman, Antimicrobial activity of silver containing dressings on wound microorganisms using an in vitro biofilm model, Int. Wound J 4 (2007) 186–191.
[2] A.R. Shahverdi, A. Fakhimi, H.R. Shahverdi, S. Minaian, Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli, Nanomedicine 3 (2007) 168–171.
[3] J.M. Nam, C.S. Thaxton, C.A. Mirkin, Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 301 (2003) 1884–1886.
[4] J.P. Guggenbichler, M. Boswald, S. Lugauer, T. Krall, A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters, Infection 27 (1999) 16–23.
[5] I. Sondi, B. Salopek-Sondi, Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275 (2004) 177–182.
[6] J.L. Elechiguerra, J.L. Burt, J.R. Morones, A. Camacho-Bragado, X. Gao, H.H. Lara, M.J. Yacaman, Interaction of silver nanoparticles with HIV-1, J nanobiotechnology 3 (2005) 6.‏
[7] H.H. Lara, N.V. Ayala-Nunez, L. Ixtepan-Turrent, C. Rodriguez-Padilla, Mode of antiviral action of silver nanoparticles against HIV-1, J Nanobiotechnol., 8 (2010) 1.
[8] B. Borrego, G. Lorenzo, J.D. Mota-Morales, H. Almanza-Reyes, F. Mateos, E. López-Gil, ... & N. Bogdanchikova, Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo. Nanomedicine: NBM, 12 (2016) 1185-1192.‏
[9] L. Sun, A.K. Singh, K. Vig, S.R. Pillai, S.R. Singh, Silver nanoparticles inhibit replication of respiratory syncytial virus. J Biomed Biotechnol 4 (2008) 149–158.
[10] L. Lu, R.W. Sun, R. Chen, C.K. Hui, C.M. Ho, J.M. Luk, G.K. Lau, C.M. Che, Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther 13 (2008) 253–262.
[11] D.B. Pinto, S. Shukla, N. Perkas, A. Gedanken, R. Sarid, Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug Chem 20 (2009) 1497–1502.
[12] J.V. Rogers, C.V. Parkinson, Y.W. Choi, J.L. Speshock, S.M. Hussain, A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation, Nanoscale Res Lett 3 (2008) 129–133.
[13] D. Morris, M. Ansar, J. Speshock, T. Ivanciuc, Y. Qu, A. Casola, R.P. Garofalo, Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection. Viruses 11 (2019) 732.‏
[14] D.X. Xiang, Q. Chen, L. Pang, C.L. Zheng, Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J virol methods 178 (2011) 137-142.‏
[15] D. Xiang, Y. Zheng, W. Duan, X. Li, J. Yin, S. Shigdar, B. Xiang, Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int J nanomedicine 8 (2013) 4103.‏
[16] S. Gaikwad, A. Ingle, A. Gade, M. Rai, A. Falanga, N. Incoronato, M. Galdiero, Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int. J nanomed., 8 (2013) 4303.‏
[17] C. You, C. Han, X. Wang, Y. Zheng, Q. Li, X. Hu, H. Sun, The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity. Mol Biol Rep 39 (2012) 9193-9201.‏
[18] D.J. Barillo, D.E. Marx, Silver in medicine: a brief history BC 335 to present. Burns 4 (2014) 3-8.‏
[19] D. K. Tiwari, J. Takashi, J. Behari, Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats, Toxicol. Mech. Methods, 21 (2011) 13-24.‏
[20] N. Hadrup, H.R. Lam, Oral toxicity of silver ions, silver nanoparticles and colloidal silver–a review. Regul Toxicol Pharmacol, 68 (2014) 1-7.‏